Gainers
- Kezar Life Sciences (NASDAQ:KZR) shares increased by 28.2% to $0.95 during Tuesday's after-market session. The market value of their outstanding shares is at $69.2 million.
- IN8bio (NASDAQ:INAB) shares rose 13.23% to $0.26. The market value of their outstanding shares is at $18.4 million.
- Exicure (NASDAQ:XCUR) stock moved upwards by 6.53% to $2.77. The market value of their outstanding shares is at $6.0 million.
- Tivic Health Systems (NASDAQ:TIVC) shares increased by 5.05% to $0.27. The market value of their outstanding shares is at $1.6 million.
- Biora Therapeutics (NASDAQ:BIOR) stock rose 4.99% to $0.57. The company's market cap stands at $20.7 million.
- Lucid Diagnostics (NASDAQ:LUCD) stock increased by 4.99% to $0.84. The company's market cap stands at $41.5 million.
Losers
- Nexalin Technology (NASDAQ:NXL) shares decreased by 14.7% to $0.58 during Tuesday's after-market session. The company's market cap stands at $6.1 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 10.81% to $0.43. The company's market cap stands at $7.4 million.
- Exscientia (NASDAQ:EXAI) shares fell 6.24% to $4.51. The market value of their outstanding shares is at $569.9 million.
- Virios Therapeutics (NASDAQ:VIRI) stock fell 5.75% to $0.15. The market value of their outstanding shares is at $4.0 million.
- Regional Health Props (AMEX:RHE) stock decreased by 5.65% to $2.34. The company's market cap stands at $4.4 million.
- Catheter Precision (AMEX:VTAK) stock decreased by 5.0% to $0.31.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
